Beljanski Approach for Different Stages of Cancer

Precancerous condition (Stage 1)

Goal: Prevent the development of a tumor in individuals who are precancerous, with a high likelihood of developing a cancer without being diagnosed.

Characteristics of a precancerous condition:

Risk of cancer increases with age. Other risk factors: presence of inflammatory condition such as benign prostatic hyperplasia which may progress to a tumor; immediate family history of cancer; presence of urinary disorders, obesity, sedentary lifestyle, poor diet.

Beljanski approach will begin with a regimen to treat obesity, accompanied by a sweep of the body with an annual course of two months of Beljanski extracts such as Pao pereira and Rauwolfia vomitoria, in suitable doses. This treatment can prevent the development of tumors.

These extracts contain alkaloids of the beta-carboline class; alstonine (from Rauwolfia vomitoria, native to Africa) and flavopereirine (from Pao pereira, a tree that grows in Brazil ) that react to the open sites of cancerous DNA and prevent genome duplication. The cancer cell dies by apoptosis. Many patients who have taken these alkaloids regularly have been cured of their cancer, but the extracts also work to prevent progression to cancer. In addition, these alkaloids only react to open sites of cancerous DNAs so they don’t affect healthy cells. Therefore they do not exhibit toxicity at the therapeutic doses used.

Localized cancerous condition (Stages 2 and 3)

Goal: Synergy of Beljanski approach with radiotherapy and chemotherapy, reduction of side effects and preservation of immunity.

In the case of prostate, a tumor is diagnosed which remains localized to the gland and to the seminal vesicles nearby. Beljanski approach is used as an accompaniment and complement to conventional treatment by radiotherapy, chemotherapy, brachytherapy, High Intensity Focused Ultrasound and others. Beljanski treatment consists of taking extracts such as Pao pereira and Rauwolfia vomitoria, in suitable doses. This will allow an attack on the cancer cells already weakened by other therapies.

In addition, taking Beljanski’s Ginkgo biloba extract in conjunction with radiotherapy or brachytherapy will reduce the side effects of these treatments. Ginkgo biloba is a tree that survived the destructive nuclear radiation in Japan. The yellow leaf Ginkgo extract can protect tissues from radiation induced damage. This extract helps reduce the side effects of radiotherapy (and brachytherapy), and prevent fibrosis caused by radiation.

Finally, in the event of a risk of impairment of immunity during radiotherapy, a sublingual intake of Beljanski’s RNA fragments, the day before and then during the weeks of treatment, enables the return of immunity, the regeneration of platelets and neutrophils, activation of Natural Killer cells and prevention of chromosomal breaks. Beljanski’s RNA fragments are made from a safe strain of E. coli bacteria. They facilitate proliferation of healthy white blood cells and platelets, replenishing the immune system.

Advanced cancerous state (Stage 4)

Goal: Effectiveness of Beljanski extracts when chemotherapy is no longer effective.

The cancer is no longer localized, it has spread to surrounding and even distant organs including lungs, liver, lymph nodes and entered an advanced stage. Chemotherapy or hormone therapy treatments will be introduced into the bloodstream to reach the metastases.

At this stage, Beljanski treatment will be based on the Pao pereira and Rauwolfia vomitoria extracts to attack cancer cells weakened by conventional treatments. The active compounds in the extracts circulate in the blood, and in the case of Pao pereira will even reach metastases in the brain (passing the meningeal barrier). The anti-cancer activity of the extracts are all the more effective when combined with conventional treatments—synergy of action. Yellow leaf Ginkgo biloba extract for its regulatory effect on globulins and enzymatic proteins, its protection of the genome and its reduction of the side effects of radiation therapies, brings comfort to patients in aggressive treatments.

For treatments seriously affecting the hematopoietic cells, and the essential immunity of the patient, taking RNA fragments before and during treatments will protect and restore immunity (platelets and white blood cells) without inducing proliferation of malignant cells. These sublingual doses should be taken before and during chemotherapy to avoid aplasia.

In some cases, after extended therapies, the tumor has metastasized, become resistant and continues to grow. Conventional therapies then have no solution to provide. At this stage, Beljanski extracts still have the major advantage of being effective against hormone-resistant and chemo-resistant tumors.

Quote Gretchen DuBeau

"The brilliant Mirko Beljanski, PhD, found miracles in nature—Pao pereira, a tree native to the Amazon, and Rauwolfia vomitoria, which is extracted from an African root bark—that proved to heal countless patients from cancer and AIDS. You would think these would be household names, and we would all be celebrating this major milestone in the war on cancer. But we aren’t. In fact, most people don’t know anything about these two natural remedies. 'WHY?'"

Gretchen DuBeau, Esq.

Executive Director : Alliance for Natural Health, USA